|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 213/74 | |
| C07D 471/04 |
| (11) | Number of the document | 3356329 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16775340.9 |
| Date of filing the European patent application | 2016-09-27 | |
| (97) | Date of publication of the European application | 2018-08-08 |
| (45) | Date of publication and mention of the grant of the patent | 2020-04-15 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IB2016/055777 |
| Date | 2016-09-27 |
| (87) | Number | WO 2017/056001 |
| Date | 2017-04-06 |
| (30) | Number | Date | Country code |
| PCT/CN2015/0910 | 2015-09-29 | WO |
| (72) |
LUSTENBERGER, Philipp, CH
MATHES, Christian, CH
FEI, Zhongbo, CN
RISS, Bernard, CH
SCHLAMA, Thierry, CH
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | PROCESS FOR PREPARING 1-(4-METHANESULFONYL-2-TRIFLUOROMETHYL-BENZYL)-2-METHYL-1H-PYRROLO [2,3-B]PYRIDIN-3-YL-ACETIC ACID |
| PROCESS FOR PREPARING 1-(4-METHANESULFONYL-2-TRIFLUOROMETHYL-BENZYL)-2-METHYL-1H-PYRROLO [2,3-B]PYRIDIN-3-YL-ACETIC ACID |